Today, muscle atrophy is often unavoidable when you can't move due to severe injury, old age or diseases like amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). However, Harvard researchers see hope in soft robotics that could someday stretch and contract the muscles of patients unable to do so themselves.
The Harvard engineers tested a new mechanostimulation system on mice, successfully preventing or assisting in their recovery from muscle atrophy. The team implanted the "soft robotic device" on a mouse's hind limb, which they immobilized in a cast-like enclosure for around two weeks. While the control group's untreated muscles wasted away as expected, the actively stimulated muscles showed reduced degradation. The researchers believe their system can eventually lead to implants helping humans with atrophy.
Its promise stems from its ability to induce a small mechanical muscle strain that mirrors natural stimulation during exercise. Moreover, while keeping atrophy at bay, the device didn't lead to any severe tissue inflammation or damage.
"There is a good chance that distinct soft robotic approaches with their unique effects on muscle tissue could open up disease or injury-specific mechano-therapeutic avenues," said David Mooney, Ph.D., the paper's senior author and Harvard's Wyss Institute engineering faculty member.
Wyss Institute
Dubbed MAGENTA (short for "mechanically active gel-elastomer-nitinol tissue adhesive"), the anti-atrophy system includes an engineered spring made from nitinol, a shape memory alloy (SMA) that can rapidly actuate when heated. Researchers control the spring with a wired microprocessor unit that determines the frequency and duration of muscle contractions and stretches.
The system also includes an elastomer matrix forming the device's body and providing insulation for the heated SMA. In addition, a layer of "tough adhesive" keeps MAGENTA aligned with the muscles' natural movement axis while transmitting stimulation deep into muscle tissue.
"While untreated muscles and muscles treated with the device but not stimulated significantly wasted away during this period, the actively stimulated muscles showed reduced muscle wasting," said first-author and Wyss Technology Development Fellow Sungmin Nam, Ph.D. "Our approach could also promote the recovery of muscle mass that already had been lost over a three-week period of immobilization, and induce the activation of the major biochemical mechanotransduction pathways known to elicit protein synthesis and muscle growth."
The team also experimented with a wireless version, using laser light rather than electrical wiring to actuate the SMA spring. Although this approach showed reduced effectiveness due to fat tissue absorbing some of the laser light, the researchers believe this approach still holds potential and warrants further research.
If you think of robots in the military, your mind may conjure dystopian images of science-fiction battlefields with AI-powered machines trading laser fire. But in a much more humane application, UK researchers are developing a potentially lifesaving medical system equivalent to a VR triage video call.
University of Sheffield researchers are working on a telepresence system to treat military personnel during combat. The plan is for offsite medics to don virtual reality headsets and control a battlefield robot. The machine can take the patient's vitals with the same technology used in robotic surgery.
Currently, injured combatants often have to see medical technicians with limited on-hand resources. These paramedics often do their jobs at significant personal risk (and, if contagious diseases and contamination are factors, a risk to others as well). If the patient needs further care, moving them to a safe location with proper resources could take hours or days.
The planned telepresence system would allow medical technicians to work offsite, using the robot to gather data like the patient's temperature or blood pressure. For example, the machines could take mouth swabs and draw blood samples from the patient's arm. In addition, it could send photos and videos of injuries to the offsite medical workers, allowing them to assess and perhaps even treat the patient remotely.
Project co-lead Sanja Dogramadzi, a professor at the University of Sheffield's Department of Automatic Control and Systems Engineering, sees the initiative as a lifesaving measure. "Developing a remotely-operated robotic system would significantly improve safety by reducing the amount of danger military personnel are exposed to on the frontline. Our platform uses the latest technology and would integrate it in a way that hasn't been done before."
YouTube is attempting to make it easier for folks to find reliable and high-quality health information on the platform. It's opening up its health product features to certain healthcare professionals and information providers in the US. It started offering those features last year to educational institutions, public health departments, hospitals and government bodies. "This new step will allow us to expand to include high quality information from a wider group of healthcare channels," Dr. Garth Graham, the global head of YouTube Health, wrote in a blog post.
The features include labels under videos that clearly state the information is coming from a healthcare professional or accredited organization. When a user searches for a term such as "bipolar" or "breast cancer," they may see a carousel of videos under the label “From health sources” near the top of the search results.
YouTube says healthcare professionals can apply for the program starting today. They'll need to submit proof of their medical license and for their YouTube account to be in good standing. They'll also need to follow the Council of Medical Specialty Societies, the National Academy of Medicine and the World Health Organization best practices for sharing health information. YouTube plans to expand the program to more markets and other types of medical specialties.
Helping people obtain credible health information from a verified professional is inherently a positive move. YouTube will still have to tread carefully with this program, given the COVID-19 and vaccine misinformation that has been rife on the platform over the last few years. Meanwhile, YouTube points out that people shouldn't consider health-related information they learn from verified professionals as medical advice (and nor will the videos apply to everyone). You'd still be best served to get in touch with a healthcare provider if you have a medical concern and to contact emergency services if the need arises.
Despite being the wealthiest nation on the face of the planet, the United States chronically runs short of transplantable organs. Kidneys are far and away the most sought-after organ for transplantation, followed by livers. While the liver is the only human organ known capable of regenerating itself, if you damage yours badly enough for long enough — as some 30 million Americans have — then the only treatment is a transplant. Assuming you can even acquire one for doctors to stick in you. Every year demand for replacement livers outstrips supply by a scope of tens of thousands.
“Only one-third of those on the liver transplant waiting list will be transplanted, and the demand for livers is projected to increase 23 percent in the next 20 years,” a multidisciplinary team of researchers observed in 2016’s Liver-Regenerative Transplantation: Regrow and Reset. “Exacerbating the organ shortage problem, the donor pool is expected to shrink further because of the obesity epidemic. Liver steatosis [aka fatty liver disease] is increasingly common in donors and is a significant risk factor in liver transplantation.”
To address this critical shortage, the study authors note that doctors have explored a variety of cutting-edge regimens, from cell repopulation and tissue engineering, nanoparticles to genomics, mechanical aids to porcine-derived xenotransplantation, all with varying degrees of success. Cellular repopulation has been used for years, a process that injects healthy liver cells into the patient’s damaged organ through a portal vein where they adhere themselves to the existing cellular scaffolding and grow into new, functional liver tissue.
Fabian Bimmer / reuters
“Creating an immediately available and inexhaustible supply of functioning liver cells from autologous tissue would allow early intervention in patients with hepatic failure and would allow liver cells to be infused over a longer period of time,” the 2016 study’s authors note. “Combined with recent advances in genome-editing technology, such liver cells could be used widely to treat devastating liver-based inborn errors of metabolism and to eliminate the need for a life-long regimen of immunosuppressive drugs and their complications.” The downside to this technique is the pace at which the donor cells proliferate, making it a poor tool against acute liver failure.
Extracellular Vesicle-based therapies, on the other hand, leverage the body’s intracellular communications pathways to deliver drugs with, “high bioavailability, exceptional biocompatibility, and low immunogenicity,” according to 2020’s Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations. “They provide a means for intercellular communication and the transmission of bioactive compounds to targeted tissues, cells, and organs” including “fibroblasts, neuronal cells, macrophages, and even cancer cells.”
EVs are the postal letters that cells send one another. They come in a variety of sizes from 30 to 1000 nm and have exterior membranes studded with multiple adhesive proteins that grant them entry into any number of different types of cells. Exploiting the biological equivalent to a janitor’s key ring, researchers have begun tucking therapeutic nanoparticles into EVs and using them to discreetly inject treatments into the targeted cells. However, these treatments are still in the experimental stages and are most effective against acute liver failure and inborn metabolic diseases rather than end-stage liver failure.
Mayo Clinic
Mechanical aids, the hepatocytic equivalent to a dialysis machine, like the Mayo Spheroid Reservoir Bioartificial Liver (SRBAL, above) are ideal for treating cases of acute liver failure, able to take over the entirety of the patient’s liver function externally and immediately. However, such procedures are both expensive and temporary. The SRBAL can only support a patient for up to two weeks, making it more suitable for keeping someone alive until a donor can be located rather than as a permanent, pacemaker-like solution.
No matter where the transplanted organ comes from, getting it into the patient is invariably going to involve a significant surgical procedure. However, the Lygenesis company recently unveiled its non-invasive solution: tricking the patient’s body into growing a series of miniature, ectopic liver “organoids” in its own lymphatic system like a crop of blood-scrubbing potatoes.
For those of you who dozed through high school bio, a quick recap of terms. The lymphatic system is a part of the immune system that serves to circulate some 20 liters of lymph throughout your body, absorb excess interstitial fluids back into the bloodstream, and incubate critical lymphocytes like T-cells. Organoids, on the other hand, are biological masses artificially grown from stem cells that perform the same functions as natural organs, but do so ectopically, in that they function in a different part of the body as a regular liver. Blood-scrubbing potatoes are self-explanatory.
“Fundamentally, Lygenesis uses the lymph node, your body's natural bio reactors typically used for T-cells,” company CEO and co-founder Michael Hufford, told Engadget. “We hijacked that same biology, we engraft our therapies into the lymph nodes to grow functioning ectopic organs.”
“We use an outpatient endoscopic ultrasound procedure where we're going down through the mouth of the patient using standard endoscopic equipment,” Hufford continued. “We engraft ourselves there in minutes under light sedation, so it's very low medical risk and also is really quite inexpensive.” He notes that the average cost for a proper, in-hospital liver transplant will set you back around a million dollars. Lygenesis’ outpatient procedure “is billed at a couple of thousand or so,” he said.
More importantly, the Lygenesis technique doesn’t require a full donated liver, or even a large fraction of one. In fact, each donated organ can be split among several dozen recipients. “Using our technology a single donated liver can reach 75 or more patients,” Hofford said. The process of converting a single donated liver into all those engraftable samples takes a team of three technicians more than six hours and 70 steps to complete. The process does not involve any gene manipulation, such as CRISPR editing.
This process is quite necessary as patients cannot donate culturable liver cells to themselves. “Once you have end-stage liver disease, you typically have a very fibrotic liver,” Hofford noted. “It will bleed at the slightest sort of intervention.” Even the simple act of collecting cellular samples can quickly turn deadly if the wrong bit of organ is bisected.
And it’s not only the transplant recipients themselves who are unable to donate. Hofford estimates between 30 and 40 percent of donated livers are too worn to be successfully transplanted. “One of the benefits of our technology is we're using organs that have been donated but will otherwise be discarded,” he said.
Once engrafted into a lymph node, the liver organoid will grow and vascularize over the course of two to three months, until it is large enough to begin supporting the existing liver. Hufford points out that even with end-stage disease, a liver can retain up to 30 percent of its original functionality, so these organoids are designed to augment and support the existing organ rather than replace it outright.
Lygenesis is currently in Phase 2A of the FDA approval process, meaning that a small group of four patients have each received a single engraftment in a lymph node located in their central body cavity near the liver itself (the body has more than 500 lymph nodes and apparently this treatment can technically target any of them). Should this initial test prove successful subsequent study groups will receive increasing numbers of engraftment, up to a half dozen, to help the company and federal regulators figure out the optimal number of organoids to treat the disease.
While the liver’s inherent regenerative capabilities make it an ideal candidate for this procedure, the company is also developing similar treatments for the kidneys, pancreas and thymus gland as well as inborn metabolic liver ailments like maple syrup urine disease. These efforts are all at much earlier points in development than the company’s end stage liver work. “Within the next five years, we would love to see our liver program submitted to the FDA as a new biologic therapy and be commercially available,” Hufford said. “I think that'd be a realistic timeframe.”
Adults in the US with mild-to-moderate hearing loss can now buy hearing aids online or from a store without a prescription, medical exam or audiologist fitting. The Food and Drug Administration issued a final rule in August that allows stores and online retailers to sell over-the-counter (OTC) devices starting today.
The move could save consumers thousands of dollars on a pair of hearing aids, according to the White House. Walmart is now selling them through its website, Sam's Club, more than 1,000 in-store Vision Centers and 474 Sam’s Club Hearing Aid Center locations. Walmart's options cost between $199 and $999 per pair. The company claimed comparable prescription hearing aids cost between $4,400 and $5,500.
Walgreens and CVS are also now selling OTC hearing aids. Best Buy and Hy-Vee will begin selling them online this week and in stores a little later.
Last week, Sony announced two hearing aid models that it created with WS Audiology. The CRE-C10 has a battery life of up to 70 hours on a single charge, according to Sony. That model will be available sometime this month. The CRE-E10, meanwhile, will cost $1,300. Sony claims it has a battery life of 26 hours, though you'll be able to recharge it wirelessly. The CRE-E10 can also connect to an iPhone for audio playback.
Jabra revealed a set of hearing enhancement earbuds in August 2021. While they were initially available from hearing care clinics, but Jabra says they're now on sale as OTC hearing aids. Early last year, Bose announced what it claimed were the first FDA-cleared hearing aids that don't need a prescription or visit to a doctor.
Nearly 30 million Americans are believed to have some degree of hearing loss, including 10 million folks under the age of 60. Over-the-counter hearing aids could drastically improve many people's quality of life, especially since the devices should be far less expensive. However, those who have severe hearing loss or anyone aged under 18 will still need a prescription for hearing aids, the FDA ruled.
Earlier this summer, the US FDA greenlit the sale of over-the-counter (OTC) hearing aids, and now we're seeing some from one of the largest audio companies in the world. Sony has announced the availability of its first OTC hearing aids, the $1,000 CRE-C10 and $1,300 CRE-E10, built in partnership with WS Audiology.
The devices are built for daily use for those with mild to moderate hearing loss. They're controlled via Sony's "Hearing Control" app that guides users through setup and allows them to personalize settings like volume control. It also allows a "self-fit" that adjusts to appropriate pre-defined hearing profiles "based on thousands of actual, real-life audiogram results," Sony said.
Sony Electronics, Inc.
The CRE-C10 model (above) offers a battery life of up to 70 hours of continuous use. Sony says they're one of the smallest OTC hearing aids on the market, offering a discreet design that's "virtually invisible when worn" and "exceptional sound quality." It goes on sale this month for $1,000 at Amazon, Best Buy, and select hearing-care professionals.
Meanwhile, the CRE-E10 (at top) has a more earbud-like design, powered by a rechargeable battery with up to 26 hours of life between charges. It's Bluetooth compatible as well, so users can connect to devices and listen to streaming audio or music, though only on iOS, Sony says. Those will go on sale for $1,300 sometime this winter at Sony's website.
Last year, Bose and Lexie unveiled their own OTC hearing aids with the SoundControl lineup, and launched the first B1 model for $900 a couple of days ago. Companies like Jabra have also leaped in. And last year, Sennheiser sold its consumer audio business to the hearing aid specialist Sonova. While the prices are still not what you'd call cheap, they're far less than prescription hearing aids that can run $1,000-$4,000 per ear, according to Consumer Reports.
Amazon wants to help you get better understanding of your sleep, but knows that many of us hate wearing something to bed just to track our rest. That's why it made the Halo Rise — a bedside lamp and sleep tracker that works without a camera or microphone to track the person resting closest to it. It'll also use machine learning to detect what sleep zones you're in and will cost $140 when it's available later this year.
It uses a "no-contact, low-energy sensor" to sense movement and respiratory patterns. Together with machine learning, Amazon can tell from the rising and falling or expanding and contracting of your body to determine your sleep stages throughout the night. Amazon says it "trained and validated the device's sleep algorithm against the clinical gold standard for sleep analysis called... overnight polysomnography."
If there's another person or animal sharing your bed, Amazon said its algorithm can detect and exclude their activity and only include your data in your sleep summary, which you'll see every day. The company will then offer you tips on how to sleep better, including suggestions on how to optimize your environment.
The Rise also has sensors to gauge the temperature, humidity and brightness of your room, and is also a lamp. It'll glow in accordance with sunrise times so you can wake up to a gradually brightening grow instead of having your retinas scorched off when you open your curtains. You can also set a smart alarm that will monitor your sleep stages and wake you at an ideal time instead of disrupting you in the middle of deep sleep.
The Rise will also work with Alexa and you can set a compatible Alexa device to start playing your favorite song as you're waking up, based on the Rise's insights. If you have personalized sleep routines, the Rise can also trigger them when you get in bed, turning off your lights and other devices for you.
Those concerned about privacy can turn off the sleep-tracking sensor whenever they want, and Amazon said that all Halo health data is encrypted in transit and at rest in the cloud. You'll also be able to download your health data, limit access to it or delete it altogether.
Though Amazon describes this as a "first of its kind bedside sleep tracker," Google already introduced something similar last year with the second-generation Nest Hub. That device uses the company's Soli radar sensor to monitor your breathing and is designed to be used by your bed, too. It doesn't offer the alarm and lights that the Halo Rise does, but is based on the same principle.
This story is developing, please refresh for updates...
Follow all of the news from Amazon's event right here!
The Japanese government has earmarked $2 billion in funding for vaccine research in an effort to make sure its country is better prepared for any future pandemic, according to Nature. Japan lagged behind other countries not just in developing vaccines, but also in approving them when it came to COVID-19. As the publication points out, three of Japan's most advanced COVID-19 vaccine candidates are still undergoing clinical trials. To prevent a repeat, the country established the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) back in March.
SCARDA's central research center will be based in Tokyo, but it will be supported by four core institutes, namely Osaka University, Nagasaki University, Hokkaido University and Chiba University. The $2 billion funding is supposed to keep it running for five years. $1.2 billion will go towards the center's vaccine research and development projects, while $400 million will be spent on supporting start-ups in drug development. The other $400 million will go towards setting up a network of research centers across the nation, as well as towards vaccine testing.
SCARDA will initially focus on developing vaccines for eight infectious diseases, including COVID-19, monkeypox, SARS, dengue and Zika virus. Its researchers will look into various types of vaccine technologies, as well, such as mRNA and viral vectors. The center aims "to find seeds for future vaccines," but its ultimate goal is to be able to conjure up diagnostic tests, vaccines and treatments within 100 days of the identification of a pathogen that has the potential to become a pandemic.
It was the UK government that first proposed the 100-day response goal, based on what it learned from COVID-19. "The first 100 days when faced with a pandemic or epidemic threat are crucial to changing its course and, ideally, preventing it from becoming a pandemic," the UK wrote in its pandemic preparedness report to the G7. According to the World Health Organization, it recorded over 2.5 million cases and 200,000 deaths 100 days after it declared COVID-19 as a public health emergency of international concern. A swift response from the start could've prevented those numbers from getting any higher.
More evidence is mounting that virtual reality might relieve pain during surgery. MIT Newsreports that Beth Israel Deaconess Medical Center researchers in Boston have published a study indicating that patients wearing VR headsets required less anesthetic during hand surgery. While the average conventional patient needed 750.6 milligrams per hour of the sedative propofol, people looking at relaxing VR content (such as meditation, nature scenes and videos) only required 125.3 milligrams. They also recovered earlier, leaving the post-anesthesia unit after 63 minutes on average versus 75 minutes.
The scientists claim VR distracted the patients from pain that would otherwise command their full attention. However, the researchers also admitted that the headset wearers may have gone into the operating room expecting VR to help, potentially skewing the results.
Beth Israel Deaconess' team is planning trials that could rule out this placebo effect, though. One follow-up trial will also gauge the effect of VR on patients receiving hip and knee surgery. Past experiments, such as at St. Jospeph's Hospital in France, have indicated that the technology can help assuage patients.
The allure for healthcare providers is clear. Patients might suffer less and return home sooner. Hospitals, meanwhile, could make the most of their anesthetic supplies, free recovery beds and reduce wait times. What a provider spends on VR headsets could pay for itself if it allows for more patients and higher-quality treatment.
Maybe you like to run, or perhaps you’re many years into a regular gym habit. You’ve dabbled with fitness wearables and thought about treating yourself to a massage gun, but never got around to buying one. Perhaps your foam roller is starting to crumble, and that free tee you got with protein powder has seen better days. You might be fitter, but your fitness equipment and tech are due for an upgrade.
The Engadget team has picked some of their favorite exercise tech purchases that have made our fitness journeys less of a struggle. From the best wearable tech to our favorite smart scale, some selections command premium prices, while a few are surprisingly affordable.
Oura Ring
Mat Smith / Engadget
As we said in our review, the Oura ring is a wearable for people who hate wearables. It also offers more robust sleep tracking than many watch-like devices. Despite the size and weight remaining unchanged from the second-gen Oura ring, it’s incredible how much technology is crammed into this thing. The third generation has sensors that can track your heart rate continuously; temperature monitoring; blood oxygenation; and period prediction.
The Oura ring is very serious about tracking everything it can. Given the lack of a display, you’ll need your smartphone to check on your recovery scores and how well you slept. These scores are synthesized from biometrics, including your heart rate variability, body temperature, resting heart rate and breathing rate. With a subscription – yes, something you may have to pay beyond the $299 asking price – you’ll get weekly summaries to show how your activity levels and sleeping hours are trending. I like Oura’s ability to tell when you’ve been training a little too hard and that the app suggests taking a day off to recover.
The ring isn’t perfect. The company has let some features drag for months – especially frustrating when some users pay a monthly sub. For example, blood oxygenation (SpO2) level tracking was promised when the third-gen Oura Ring was first announced and has only just arrived on most rings – almost half a year late.
A warning: If you’re planning to track weight lifting workouts with the Oura ring, the black edition is likely to show some conspicuous scratches if you’re gripping metallic bars and plates. I also struggled with pull-ups, as I’m not quite used to wearing a ring while gripping for my life. – Mat Smith, UK Bureau Chief
The most popular smartwatch series continues to lead on the feature front – if you ignore sleep tracking. The Series 7 has the biggest screen yet of any Apple Watch. It’s over 50 percent bigger than the Series 3 and 20 percent larger than the Series 6 that came before it. With more screen space and bigger buttons, it’s easier to stop and start workouts and check your heart rate and time elapsed during exercise. In addition, since watchOS 5, Apple’s wearables have been able to auto-detect specific workouts, which is great for when you forget to start logging a run or a spin session.
The Series 7 can track your VO2 Max levels, measuring your cardiorespiratory fitness level. What’s cool here is how the wearable notifies you when your levels tangibly change. So if you start a new intensive workout regime, you’ll see these figures creep up. Your iPhone will notify you when you make tangible improvements, say moving from below to above average cardio fitness levels, possibly even to its high fitness level. I’ve been hovering around 50 VO2 Max, but I’ll get to 52 eventually.
The Apple Watch also has its own connected workout platform in the form of Fitness+, offering HIIT, dance, pilates, yoga classes and more, streaming classes to your iPhone, iPad, Mac or Apple TV. Your heart rate will show on screen during many classes, indicating how you’re faring compared to other Fitness+ members and hopefully inspiring you to push a little harder.
Of course, Apple Watch Series 8 (as well as a new 'pro' Ultra model) are both launching very soon. The Watch Ultra, in particular, packs longer battery life and a brighter screen — perfect for outdoor sports. – M.S.
Theragun’s unique triangle design helps its devices stand out from a legion of other massage therapy guns. Multiple ways to grip the Theragun make it easier to target trickier body parts. As one of the more premium massage devices, it offers 16mm amplitude (typically only bested by devices several hundred dollars more) and speeds of up to 2,400 percussions per minute. Some health claims (like improved performance) are backed up by limited studies, but others (including sped-up muscle recovery) are not. I love using mine to target specifically tight areas; it even feels good ahead of a workout.
The Theragun Prime is better than most of the massage gun competition. It’s more flexible, too. Compared to Therabody’s own more basic options, the Prime comes with three extra attachments in addition to the standard ball: a cone, a dampener with a flattened head, and a thumb attachment, which can help dig deeper. The battery is thankfully long-lasting, too. – M.S.
It’s time to throw away that chunky analog scale with the wobbly dial. Instead, for a more aesthetically pleasing design and deeper insight into your body weight and composition, it’s time to go digital. Several smart scale options are available, but I’ve used the sensibly priced Eufy Smart Scale P1. This smart scale connects with your smartphone to sync your data, and you just need to remember to open the app. Otherwise, it won’t track your progress.
It can monitor your weight in imperial or metric measurements and even make a rough guess at your body fat and water percentages. However, it’s worth noting that domestic smart scales are often not hugely accurate at gauging these measurements.
There are even more advanced smart scales too. Still, they are usually over double the price of the Smart Scale P1, often adding unnecessary features like multiple user profiles, Alexa voice activation, athletic modes for pro athletes and more. At some point, it’s diminishing returns, but the ability to digitally track (as well as set up weigh-in reminders) helped me form better habits to monitor my weight. – M.S.
Many true wireless earbuds, let alone conventional headphones, weren’t made for working out. Some have non-removable parts that can get gunked up, while others lack water and dust resistance or have wires liable to tangle up or tug at you during workouts. For many of these reasons, I swear by true wireless earbuds and the Beats Fit Pro deliver on everything I want from workout buds. That includes active noise cancellation (less weight slamming and awful gym music), an understated profile, and a comfortable fit with a convenient fin design to lock it into your ear without making your ears ache.
Thankfully, they don’t stick out your ears like many earbud options. The company recently launched a series of even more subtle skin-colored buds in collaboration with Kim Kardashian. With Apple’s H1 chip, the Beats Fit Pro can offer hands-free Siri functionality and enhanced Find My item tracking. – M.S.
One of the best things I've done for my fitness routine as of late is introducing some variety. Since I work out in the morning right after waking up, it's pretty easy for me to fall into a routine of doing the same thing over and over again. However, I've found it much easier to switch things up by relying on an on-demand fitness subscription.
I've tried a handful of the many services out there now, but the ones I've stuck with are Peloton and Alo Moves. I don't own a single piece of Peloton hardware; I instead spend $13 each month for app access only, and that's where I take most of my strength-training classes. I like that they're constantly putting out new offerings every day, but the backlog of on-demand classes is bursting at the seams, too. The sessions are challenging and engaging, and there are plenty of options if you don't have any equipment at all.
Alo Moves is more focused on yoga, pilates and barre, and it’s a bit more expensive at $20 per month. I'm more interested in toning than bulking up, so I try to incorporate some of these classes into my strength training routine. I particularly like that Alo Moves has a "series" of sessions that fall under the same umbrella that you can take over the course of many days. When I really don't want to think about what I'm doing on a given morning for a workout, it's easy just to turn to the next class in the barre series I was already working on. – Valentina Palladino, Senior Commerce Editor
For a lot of us, space is at a premium. We might have enough space to roll out a yoga mat, but not much more beyond that. Consolidating (and shrinking) your home workout gear is a nice way to keep your exercise habits going without tripping over weights or resistance band. Bowflex is a well-established fitness company that’s made adjustable dumbbells for several years now. The weight range will depend on the model, but the Bowflex SelectTech 552i can be dialed (literally) down to 2kg (4.4 pounds) and up to 24kg (53 pounds) each, making them suitable for all kinds of full-body and dedicated muscle group moves. A dial on each side of the weight adjusts how many plates the bar latches onto, with the remaining weight staying behind in the included storage tray.
There are several adjustable dumbbells out there, but I prefer this classic ‘dumbbell’ look compared to some of the more squarish-looking rivals. One minor issue is that you’ll have to tinker with both sides to adjust the weight. Also, if you’re looking for an on-demand workout service, Bowflex includes a free one-year subscription to its JRNY streaming service. – M.S.
